Kolexia
Aerts Isabelle Pédiatrie
Aerts Isabelle
Pédiatrie
Clcc Institut Curie
Paris, France
197 Activités
35 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Rétinoblastome Gliome Récidive tumorale locale Tumeurs de la rétine Tumeurs du cerveau Neuroblastome Ostéosarcome Tumeurs osseuses Sarcomes

Collaborateurs

Voir plus
Doz Francois
Doz Francois
Clcc Institut Curie, Paris, France
Geoerger Birgit
Geoerger Birgit
Gustave-Roussy, Villejuif, France
Andre Nicolas
Andre Nicolas
Hôpital La Timone Enfants, Marseille, France
Leblond Pierre
Leblond Pierre
Centre Léon-Bérard, Lyon, France

Industries

Voir plus
MSD
1 collaboration(s)
Dernière en 2020
Lilly
1 collaboration(s)
Dernière en 2022
AstraZeneca
1 collaboration(s)
Dernière en 2022
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma: A Phase 1b/2 Study of Abemaciclib in Combination With Irinotecan and Temozolomide (Part A) and Abemaciclib in Combination With Temozolomide (Part B) in Pediatric and Young Adult Patients With Relapsed/Refractory Solid Tumors and Abemaciclib in Combination With Dinutuximab, GM-CSF, Irinotecan, and Temozolomide in Pediatric and Young Adult Patients With Relapsed/Refractory Neuroblastoma (Part C)
Essai Clinique (Lilly)   27 février 2024
Study of Talimogene Laherparepvec In Children With Advanced Non CNS Tumors: A Phase 1, Multi-center, Open-label, Dose De-escalation Study to Evaluate the Safety and Efficacy of Talimogene Laherparepvec in Pediatric Subjects With Advanced Non Central Nervous System Tumors That Are Amenable to Direct Injection
Essai Clinique (Amgen)   15 février 2024
The RELIVE consortium for relapsed or refractory pediatric hepatoblastoma and hepatocellular carcinoma: a scoping review of the problem and a proposed solution.
EClinicalMedicine   15 février 2024
COTESARC: A Multicentre, Open-label, Phase I-II Study Evaluating the Combination of a MEK Inhibitor and a PDL1 Inhibitor in Pediatric and Adult Patients With Locally Advanced and/or Metastatic Soft Tissue Sarcoma.
Essai Clinique (Centre Léon-Bérard)   09 février 2024
Mutational signature, cancer driver genes mutations and transcriptomic subgroups predict hepatoblastoma survival.
European journal of cancer (Oxford, England : 1990)   01 février 2024
Adjuvant Treatment in Extensive Unilateral Retinoblastoma Primary Enucleated (RB SFCE 2009): Adjuvant Treatment in Extensive Unilateral Retinoblastoma Primary Enucleated
Essai Clinique (Institut Curie)   29 janvier 2024
RETINO2011: Conservative Treatments of Retinoblastoma
Essai Clinique (Institut Curie)   29 janvier 2024
E7080-G000-231: An Open-Label, Multicenter Phase 2 Basket Study to Evaluate the Antitumor Activity and Safety of Lenvatinib in Children, Adolescents, and Young Adults With Relapsed or Refractory Solid Malignancies
Essai Clinique (Merck & Co.)   08 janvier 2024
METRO-PD1: Phase 1 study of nivolumab in combination with metronomic chemotherapy in children and adolescents with relapsing/refractory solid tumors.
European journal of cancer (Oxford, England : 1990)   06 janvier 2024
Phase I/II study of the WEE1 inhibitor adavosertib (AZD1775) in combination with carboplatin in children with advanced malignancies: Arm C of the AcSé-ESMART trial.
Clinical cancer research : an official journal of the American Association for Cancer Research   05 décembre 2023